IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v13y2016i2p198-d63562.html
   My bibliography  Save this article

Health Impact Assessment for Second-Hand Smoke Exposure in Germany—Quantifying Estimates for Ischaemic Heart Diseases, COPD, and Stroke

Author

Listed:
  • Florian Fischer

    (Department of Public Health Medicine, School of Public Health, Bielefeld University, 33615 Bielefeld, Germany)

  • Alexander Kraemer

    (Department of Public Health Medicine, School of Public Health, Bielefeld University, 33615 Bielefeld, Germany)

Abstract

Evidence of the adverse health effects attributable to second-hand smoke (SHS) exposure is available. This study aims to quantify the impact of SHS exposure on ischaemic heart diseases (IHD), chronic obstructive pulmonary diseases (COPD), and stroke in Germany. Therefore, this study estimated and forecasted the morbidity for the three outcomes in the German population. Furthermore, a health impact assessment was performed using DYNAMO-HIA, which is a generic software tool applying a Markov model. Overall 687,254 IHD cases, 231,973 COPD cases, and 288,015 stroke cases were estimated to be attributable to SHS exposure in Germany for 2014. Under the assumption that the population prevalence of these diseases and the prevalence of SHS exposure remain constant, the total number of cases will increase due to demographic aging. Assuming a total eradication of SHS exposure beginning in 2014 leads to an estimated reduction of 50% in cases, compared to the reference scenario in 2040 for all three diseases. The results highlight the relevance of SHS exposure because it affects several chronic disease conditions and has a major impact on the population’s health. Therefore, public health campaigns to protect non-smokers are urgently needed.

Suggested Citation

  • Florian Fischer & Alexander Kraemer, 2016. "Health Impact Assessment for Second-Hand Smoke Exposure in Germany—Quantifying Estimates for Ischaemic Heart Diseases, COPD, and Stroke," IJERPH, MDPI, vol. 13(2), pages 1-11, February.
  • Handle: RePEc:gam:jijerp:v:13:y:2016:i:2:p:198-:d:63562
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/13/2/198/pdf
    Download Restriction: no

    File URL: https://www.mdpi.com/1660-4601/13/2/198/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Stefan Kohler & Philipp Minkner, 2014. "Smoke-Free Laws and Direct Democracy Initiatives on Smoking Bans in Germany: A Systematic Review and Quantitative Assessment," IJERPH, MDPI, vol. 11(1), pages 1-16, January.
    2. Hendriek Boshuizen & Stefan Lhachimi & Pieter Baal & Rudolf Hoogenveen & Henriette Smit & Johan Mackenbach & Wilma Nusselder, 2012. "The DYNAMO-HIA Model: An Efficient Implementation of a Risk Factor/Chronic Disease Markov Model for Use in Health Impact Assessment (HIA)," Demography, Springer;Population Association of America (PAA), vol. 49(4), pages 1259-1283, November.
    3. Max, W. & Sung, H.-Y. & Shi, Y., 2012. "Deaths from secondhand smoke exposure in the United States: Economic implications," American Journal of Public Health, American Public Health Association, vol. 102(11), pages 2173-2180.
    4. repec:cai:popine:popu_p1998_10n1_0136 is not listed on IDEAS
    5. Jonathan Karnon, 2003. "Alternative decision modelling techniques for the evaluation of health care technologies: Markov processes versus discrete event simulation," Health Economics, John Wiley & Sons, Ltd., vol. 12(10), pages 837-848, October.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Lih-Wen Mau & Jaime M. Preussler & Linda J. Burns & Susan Leppke & Navneet S. Majhail & Christa L. Meyer & Tatenda Mupfudze & Wael Saber & Patricia Steinert & David J. Vanness, 2020. "Healthcare Costs of Treating Privately Insured Patients with Acute Myeloid Leukemia in the United States from 2004 to 2014: A Generalized Additive Modeling Approach," PharmacoEconomics, Springer, vol. 38(5), pages 515-526, May.
    2. Annemieke Leunis & W. Redekop & Kees van Montfort & Bob Löwenberg & Carin Uyl-de Groot, 2013. "The Development and Validation of a Decision-Analytic Model Representing the Full Disease Course of Acute Myeloid Leukemia," PharmacoEconomics, Springer, vol. 31(7), pages 605-621, July.
    3. Hossein Haji Ali Afzali & Jonathan Karnon & Jodi Gray, 2012. "A proposed model for economic evaluations of major depressive disorder," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 13(4), pages 501-510, August.
    4. Mattias Ekman & Peter Lindgren & Carolin Miltenburger & Genevieve Meier & Julie Locklear & Mary Chatterton, 2012. "Cost Effectiveness of Quetiapine in Patients with Acute Bipolar Depression and in Maintenance Treatment after an Acute Depressive Episode," PharmacoEconomics, Springer, vol. 30(6), pages 513-530, June.
    5. Olivier Ethgen & Baudouin Standaert, 2012. "Population–versus Cohort–Based Modelling Approaches," PharmacoEconomics, Springer, vol. 30(3), pages 171-181, March.
    6. Leslie Anne Campbell & John T. Blake & George Kephart & Eva Grunfeld & Donald MacIntosh, 2017. "Understanding the Effects of Competition for Constrained Colonoscopy Services with the Introduction of Population-level Colorectal Cancer Screening," Medical Decision Making, , vol. 37(2), pages 253-263, February.
    7. James A. Hall & Kika Konstantinou & Martyn Lewis & Raymond Oppong & Reuben Ogollah & Sue Jowett, 2019. "Systematic Review of Decision Analytic Modelling in Economic Evaluations of Low Back Pain and Sciatica," Applied Health Economics and Health Policy, Springer, vol. 17(4), pages 467-491, August.
    8. An Tran-Duy & Annelies Boonen & Wietske Kievit & Piet Riel & Mart Laar & Johan Severens, 2014. "Modelling Outcomes of Complex Treatment Strategies Following a Clinical Guideline for Treatment Decisions in Patients with Rheumatoid Arthritis," PharmacoEconomics, Springer, vol. 32(10), pages 1015-1028, October.
    9. Jeonghoon Kim & Hyunkyung Ban & Yunhyung Hwang & Kwonchul Ha & Kiyoung Lee, 2016. "Impact of Partial and Comprehensive Smoke-Free Regulations on Indoor Air Quality in Bars," IJERPH, MDPI, vol. 13(8), pages 1-11, July.
    10. Schulenburg J.-Matthias Graf von der & Vauth Christoph, 2007. "Nach welchen ökonomischen Methoden sollten Gesundheitsleistungen in Deutschland evaluiert werden? / According to Which Economic Methods Should Health Care Services Become Evaluated in Germany?," Journal of Economics and Statistics (Jahrbuecher fuer Nationaloekonomie und Statistik), De Gruyter, vol. 227(5-6), pages 787-806, October.
    11. Ashley L Merianos & Roman A Jandarov & Judith S Gordon & Michael S Lyons & E Melinda Mahabee-Gittens, 2021. "Healthcare resources attributable to child tobacco smoke exposure," PLOS ONE, Public Library of Science, vol. 16(2), pages 1-13, February.
    12. Matthew J. Glover & Edmund Jones & Katya L. Masconi & Michael J. Sweeting & Simon G. Thompson, 2018. "Discrete Event Simulation for Decision Modeling in Health Care: Lessons from Abdominal Aortic Aneurysm Screening," Medical Decision Making, , vol. 38(4), pages 439-451, May.
    13. Catherine Lejeune & Kazem Al Zahouri & Marie-Christine Woronoff-Lemsi & Patrick Arveux & Alain Bernard & Christine Binquet & Francis Guillemin, 2005. "Use of a decision analysis model to assess the medicoeconomic implications of FDG PET imaging in diagnosing a solitary pulmonary nodule," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 6(3), pages 203-214, September.
    14. K Cooper & S C Brailsford & R Davies, 2007. "Choice of modelling technique for evaluating health care interventions," Journal of the Operational Research Society, Palgrave Macmillan;The OR Society, vol. 58(2), pages 168-176, February.
    15. Beate Jahn & Karl Peter Pfeiffer & Engelbert Theurl & Jean-Eric Tarride & Ron Goeree, 2010. "Capacity Constraints and Cost-Effectiveness: A Discrete Event Simulation for Drug-Eluting Stents," Medical Decision Making, , vol. 30(1), pages 16-28, January.
    16. Martina Otavova & Herman Oyen & Renata T. C. Yokota & Rana Charafeddine & Luk Joossens & Geert Molenberghs & Wilma J. Nusselder & Hendriek C. Boshuizen & Brecht Devleesschauwer, 2020. "Potential impact of reduced tobacco use on life and health expectancies in Belgium," International Journal of Public Health, Springer;Swiss School of Public Health (SSPH+), vol. 65(2), pages 129-138, March.
    17. Anna Choi & Dhaval Dave & Joseph J. Sabia, 2016. "Smoke Gets in Your Eyes: Medical Marijuana Laws and Tobacco Use," NBER Working Papers 22554, National Bureau of Economic Research, Inc.
    18. L. B. Standfield & T. A. Comans & P. A. Scuffham, 2017. "An empirical comparison of Markov cohort modeling and discrete event simulation in a capacity-constrained health care setting," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 18(1), pages 33-47, January.
    19. Lemoine, Coralie & Loubière, Sandrine & Boucekine, Mohamed & Girard, Vincent & Tinland, Aurélie & Auquier, Pascal, 2021. "Cost-effectiveness analysis of housing first intervention with an independent housing and team support for homeless people with severe mental illness: A Markov model informed by a randomized controlle," Social Science & Medicine, Elsevier, vol. 272(C).
    20. Jonathan Karnon & Hossein Haji Ali Afzali, 2014. "When to Use Discrete Event Simulation (DES) for the Economic Evaluation of Health Technologies? A Review and Critique of the Costs and Benefits of DES," PharmacoEconomics, Springer, vol. 32(6), pages 547-558, June.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:13:y:2016:i:2:p:198-:d:63562. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.